– The need for a supportive regulatory environment.
– An effective and efficient regulatory framework that allows timely review and early adoption of new medicines
and vaccines is essential.
– Regulators should work with industry to understand and embrace new technologies used in the discovery
and development of new products and the new challenges to the regulatory approval process they create.
– Whilst patient safety is paramount, regulation of clinical research should be competitive, allow quick start up
of clinical trials and facilitate rapid patient recruitment.
– A focus on better regulation, to ensure regulations are clear, evidence-based and proportionate, will also
encourage investment.
– It is important that high quality information is available to healthcare professionals and patients from a range
of different sources to enable clinically sound judgements to be made on the basis of quality, efficacy,
clinical-effectiveness and cost-effectiveness.